Skip to main content
OpenTrials
Completed

NCT Number: NCT03761212

Function, Locomotion, Measurement and Inflammation

FoLoMI is a pilot study in which the investigators will seek to determine if gait spatio-temporal and kinematic parameters can explain the evolution of a functional score, the Bath Ankylosing Spondylitis Functional Index (BASFI), at 18 months.

The secondary objectives are: (1) to study the relationship between gait parameters measured at T0 and the BASFI at T0, (2) to study the relationship between gait parameters at T0 and the BASDAI at T0, (3) to assess general state of health of the patients and its evolution by appreciating: level of physical activity, state of fatigue, diurnal sleepiness and quality of life, and (4) to compare spatio-temporal gait parameters between patients and healthy controls.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Grenoble Alpes - hôpital sud

Échirolles, 38100, France

About this study

This longitudinal cohort study is aiming to follow 60 persons with ankylosing spondylitis during 18 months. Assessments will be conducted at baseline and every 6 months.

An healthy control group of 30 persons will be included and age and sex matched to the first 30 patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ankylosing spondylitis or Axial Spondyloarthritis patient
  • Patient able to walk at least 180 meters without technical help
  • Stable treatment for 3 months
  • Affiliated to a social security system

Exclusion criteria

  • Concomitant musculo-skeletal disease
  • Cardio-respiratory disease with an impact on locomotion
  • Hips, ankle or knee arthroplasty (scheduled or done within 18 months)
  • No french understanding
  • Central or peripheric neurologic disease
  • Other disease with impact on posture, locomotion or prehension
  • Quickly evolutive disease (less than 12 month life expectancy)
  • Chemotherapy or radiotherapy ongoing
  • Patient who live more than 50 km away from Grenoble Hospital
  • Willing of pregnancy within 18 months
  • People protected by law (Article L1121.5 of Public Health Code)

Treatment and study plan

Primary outcomes

  1. Gait speed

    Time frame: Baseline : Day 0

    Mean gait speed (m/s) will be assessed during a 10-m walk test at comfortable speed, under single and dual task, and its coefficient of variation calculate.

  2. Stride time

    Time frame: Baseline : Day 0

    Mean stride time (s) will be assessed during a 10-m walk test at comfortable speed, under single and dual task, and its coefficient of variation calculate.

  3. Stride length

    Time frame: Baseline : Day 0

    Mean stride length (m) will be assessed during a 10-m walk test at comfortable speed, under single and dual task, and its coefficient of variation calculate.

  4. Double support time

    Time frame: Baseline : Day 0

    Double support time (%) will be assessed during a 10-m walk test at comfortable speed, under single and dual task, and its coefficient of variation calculate.

  5. Stance time

    Time frame: Baseline : Day 0

    Stance time (%) will be assessed during a 10-m walk test at comfortable speed, under single and dual task, and its coefficient of variation calculate.

  6. The Bath Ankylosing Spondylitis Functional Index (BASFI)

    Time frame: 18 months

    The self-administered Bath Ankylosing Functional Index (BASFI) measures functional consequences of ankylosing spondylitis (AS). The patient indicates its level of ability in ten domains of daily life: put the socks, bend to pick a pen from the floor, reach up to a high shelf, get up from a chair and from the floor, stand unsupported for 10 minutes, climb steps, look over the shoulder, do physically demanding activities and do a full days activities. Each question is answered on a 10 cm horizontal visual analog scale, the mean of which gives the BASFI score (0-10). Higher is the score, higher are the functional consequences of AS.

Secondary outcomes

  1. Evolution of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

    Time frame: From day 0 to 18-months

    The self-administered Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) measures disease activity. Six 10 cm horizontal visual analog scales are used to measure severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness (qualitative and quantitative). The final BASDAI score has a range from 0 to 10, with higher scores meaning higher activity of the disease.

  2. Evolution of the Bath Ankylosing Spondylitis Functional Index (BASFI)

    Time frame: From day 0 to 18-months

    The self-administered Bath Ankylosing Functional Index (BASFI) measures functional consequences of ankylosing spondylitis (AS). The patient indicates its level of ability in ten domains of daily life: put the socks, bend to pick a pen from the floor, reach up to a high shelf, get up from a chair and from the floor, stand unsupported for 10 minutes, climb steps, look over the shoulder, do physically demanding activities and do a full days activities. Each question is answered on a 10 cm horizontal visual analog scale, the mean of which gives the BASFI score (0-10). Higher is the score, higher are the functional consequences of AS.

  3. Evolution of gait pattern

    Time frame: From day 0 to 18-months

    Gait pattern will be captured by Physilog sensors (Gait Up ®) and Opal sensors (APDM®) during a 10-m walk test in single and dual task, the iTUG and the i6MWT.

  4. Evolution of physical activity

    Time frame: From day 0 to 18-months

    Patients will fill in the self-assessment questionnaire: International Physical Activity Questionnaires (IPAQ) to measure health-related physical activity. Data will be summarized according to each physical activity domain (walking, moderate and vigorous activities) and estimated time spend sitting per week. Then data will be used to estimate Metabolic Equivalent of Task (MET) energy expenditure assigned to each category.

  5. Evolution of quality of life

    Time frame: From day 0 to 18-months

    Patients will fill in the self-assessment questionnaire: Short Form-36 (SF-36) to measure quality of life. Eight domains will be assessed : physical activity, daily life limitations, physical pain, health, social life, psychological health, psychological limitations, health evolution.

  6. Evolution of daytime sleepiness

    Time frame: From day 0 to 18-months

    Patients will fill in the self-assessment questionnaire: Epworth score for evaluation of daytime sleepiness. Patients wil rate the chances that they would doze off or fall asleep while in eight different situations, from no chance to doze or sleep (0) to strong chance to sleep (3).

  7. Evolution of tiredness

    Time frame: From day 0 to 18-months

    Patients will fill in the self-assessment questionnaire: Pichot score for evaluation of daytime tiredness. This scale assess the importance of tiredness to carry out daily activities.Patients rate how the eight proposals correspond to their feeling, from not at all (0) to extremely (4).

  8. Evolution of lower limbs range of motion assessments

    Time frame: From day 0 to 18-months

    Lower limb range of motion will be assessed using a goniometer in each joint.

  9. Evolution of foot function

    Time frame: From day 0 to 18-months

    Foot function will be assessed with the validated and commonly used Foot Function Index. Participants will rate 0 to 10 on a numeric scale, in 3 domains concerning feet, i.e. pain, disability and activity restriction. The score is out of 230 and translated out of 100. Higher scores are related to worse outcome.

  10. Evolution of six minute walk distance

    Time frame: From day 0 to 18-months

    The instrumented six minute walk test (i6MWT) will be performed in a 30-m corridor.

  11. Evolution of time to realize instrumented Timed Up and Go (iTUG)

    Time frame: From day 0 to 18-month

    Patients will performed the iTUG : they have to stand up from a chair, walk 7 meters, turn and go back to the chair, as fast as possible

  12. Evolution of work impairment

    Time frame: From day 0 to 18-month

    The validated Work Productivity and Activity Impairment scale (WPAI) will be assessed to evaluate absenteeism, presenteeism, overall work productivity loss and activity impairment. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity, i.e., worse outcomes.

  13. Evolution of smoking status

    Time frame: From day 0 to 18-month

    Smoking status will be assessed with the calculation of number of pack-year smoked. It is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.

  14. Evolution of nicotine dependence

    Time frame: From day 0 to 18-month

    Smoking status will be assessed with the validated and commonly used Fagerström index, giving a score from 0 to 10, with high scores related to high dependence

  15. Evolution of social support

    Time frame: From day 0 to 18-month

    Social support will be assessed with the validated and commonly used Medical Outcome Study (MOS) Social Support Survey in French. The survey consists of four separate social support subscales and an overall functional social support index. A higher score for an individual scale or for the overall support index indicates more support.

Sponsors and collaborators

Lead sponsor

University Hospital, Grenoble

Other

Registry information

Official study title

Gait Parameters as Predictors of Functional and Activity Scores in Ankylosing Spondylitis : the FoLoMI Study

Acronym: FoLoMI

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Dec 3, 2018
Registry last updated
Nov 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.